|
|
|
|
Document Preview Finder Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Finder Agreement |
|||
|
Entities: |
||||
|
Date: |
2000 |
|||
|
Size: |
Preview shows 2KB of 9KB total |
|||
|
Price: |
$33 |
|||
|
ID: |
#281033 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
FINDER AGREEMENT
----------------
Pursuant to this Finder Agreement (this "Agreement") entered into
November 19, 1999, (the "Effective Date"), between Lakaro BioPharmaceuticals,
Inc., a company organized under the laws of the State of Delaware, having a
place of business at 216 Jaffa Rd., Sha'arei Ha'ir Jerusalem, Israel 94383 (the
"Company") and Paramount Capital, Inc., having a place of business at 787
Seventh Avenue, 48th Floor, New York, New York 10019 (the "Finder"), the parties
hereto agree:
1. In connection with the offering (the "Offering") by the Company of
Units consisting of 1,000 shares of Series A Convertible Preferred Stock, stated
value $100.00 per share (the "Preferred Stock"), the Finder will introduce the
Company to third parties (the "Introduced Parties") with the hope and intent
that the Introduced Parties will purchase Units in the Offering (an
"Investment");
2. In the event that during the term of this Agreement, an Introduced
Party makes an Investment in the Company, then the Company shall pay to the
Finder, immediately following the closing of the Investment and the transfer of
the proceeds to the Company, a placement fee in cash equal to five percent (5%)
of such Investment. In addition, the Company, immediately following the closing
of the Investment, shall grant to the Finder and/or its designees, three (3)
year warrants to purchase a number of shares of Common Stock equal to three
percent (3%) of the aggregate number of shares of Common Stock issuable upon
|
End of Preview |
Home Intelligence Services Subscriptions News About Us